Contraception Prescribing Training for Pharmacists - Location TBD Lafayette, IN
Faculty: Veronica Vernon, PharmD, Ashley Meredith, PharmD, Kate Riddell, PharmD, Jackie Campi, PharmD
7 hours CPE awarded
Registration fee: $25

This training program is accepted by the Indiana Board of Pharmacy as required training for pharmacists to prescribe hormonal contraception per statewide protocol. The program includes background, review of methods, protocol procedures, patient education, service implementation, resources for both pharmacists and patients, and prescribing authorities in Indiana.

Training made possible by grant award from the Indiana Department of Health Maternal and Child Health Division from the Access to Reproductive Health Services and Contraceptive Care. 

Register ONLY for training here (use link if not attending other Fall Conference programming). Otherwise, use Fall Conference registration link if also attending programming on September 20. You can choose this training as a track option.

Join us for a screening of "Shot in the Arm", courtesy of the Indiana Immunization Coalition, at Purdue University Pharmacy Building Atrium.

Both skeptical and hopeful, SHOT IN THE ARM explores vaccine hesitancy historically and in the context of our modern pandemic. Can we replace cynicism with healthy curiosity and bridge the political divides that make us sick?

Cost: Free for students, $15 for all other.  All proceeds benefit the Pharmacists Education Foundation, a 501(c)(3) organization dedicated to providing financial support for IPA's educational activities and awarding student scholarships. 

Register ONLY for screening here (use link if not attending other Fall Conference programming). Otherwise, use Fall Conference registration link if also attending programming on September 20. You can choose this screening as a track option.

• Headache complaints are a top reason why patients seek a pharmacist's consultation, with Pharmacy Times stating this occurs over 80,000 times a day.  Nine new novel mechanisms, unique dosing/precautions/adverse effects migraine medications have been approved by the FDA in the last 6 years. Join this session to learn more about migraine treatment.

• PAI 2030, an initiative launched by ASHP, was started in 2010 to drive pharmacy practice change at a local level and includes recommendations to ensure that the pharmacy profession meets the demands of future practice and patient care delivery models.